Literature DB >> 22125247

Femoral stress fractures associated with long-term bisphosphonate treatment.

William G Ward1, Christina J Carter, Scott C Wilson, Cynthia L Emory.   

Abstract

BACKGROUND: Recent studies have described unique clinical and radiographic characteristics of femoral stress fractures or low-energy fractures associated with long-term bisphosphonate therapy. However, it is unclear whether these fractures require subsequent surgery after the initial treatment. QUESTIONS/PURPOSES: We performed a cohort analysis of bisphosphonate-associated femoral stress fractures to (1) confirm the unique clinical and radiographic findings compared with existing literature, (2) determine whether any patients with completed fractures had no preexisting transverse stress fracture lines, (3) assess the need for additional surgical procedures, and (4) determine whether the hospital length of stay (LOS) differed for patients with prophylactic fixation of stress fractures versus fixation of completed fractures.
METHODS: We retrospectively reviewed 16 patients with 24 diaphyseal and subtrochanteric femoral stress fractures (14) or low-energy fractures (10) who had been on bisphosphonates for 3 to 10 years. Data included demographics, symptoms, medication history, radiographic characteristics, treatment parameters, LOS, and outcome. Minimum followup was 9 months (average, 44.0 months; median, 31 months; range, 9-112 months).
RESULTS: All patients had clinical and radiographic findings similar to those reported in the literature. Two of four patients sustained completed fractures after radiographs failed to reveal transverse lateral fracture lines. None of the 14 prophylactically treated impending fractures progressed or required additional surgery; however, in five of 10 femurs treated after fracture completion, six additional surgeries were performed. The average hospital LOS was shorter in patients who underwent prophylactic fixation (3.8 days) than in patients treated for completed fractures (5.6 days).
CONCLUSIONS: Bisphosphonate-associated stress fractures and completed fractures are unique, possessing subtle characteristic radiographic features. Completed fractures may occur through the thickened bone in the absence of an appreciable transverse stress fracture line. Our observations suggest prophylactic reconstruction nail fixation may avoid fracture completion and may be associated with a shorter hospital LOS and less morbidity than treatment of completed fractures. LEVEL OF EVIDENCE: Level IV, diagnostic study. See the Guidelines for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22125247      PMCID: PMC3270181          DOI: 10.1007/s11999-011-2194-2

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  19 in total

1.  Long-term safety of bisphosphonates.

Authors:  Susan M Ott
Journal:  J Clin Endocrinol Metab       Date:  2005-03       Impact factor: 5.958

2.  American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws.

Authors: 
Journal:  J Oral Maxillofac Surg       Date:  2007-03       Impact factor: 1.895

3.  Severely suppressed bone turnover: a potential complication of alendronate therapy.

Authors:  Clarita V Odvina; Joseph E Zerwekh; D Sudhaker Rao; Naim Maalouf; Frank A Gottschalk; Charles Y C Pak
Journal:  J Clin Endocrinol Metab       Date:  2004-12-14       Impact factor: 5.958

4.  Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.

Authors:  Dennis M Black; Ann V Schwartz; Kristine E Ensrud; Jane A Cauley; Silvina Levis; Sara A Quandt; Suzanne Satterfield; Robert B Wallace; Douglas C Bauer; Lisa Palermo; Lois E Wehren; Antonio Lombardi; Arthur C Santora; Steven R Cummings
Journal:  JAMA       Date:  2006-12-27       Impact factor: 56.272

5.  Nonoperative versus prophylactic treatment of bisphosphonate-associated femoral stress fractures.

Authors:  Michael B Banffy; Mark S Vrahas; John E Ready; John A Abraham
Journal:  Clin Orthop Relat Res       Date:  2011-02-25       Impact factor: 4.176

6.  Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study Group.

Authors:  H A Pols; D Felsenberg; D A Hanley; J Stepán; M Muñoz-Torres; T J Wilkin; G Qin-sheng; A M Galich; K Vandormael; A J Yates; B Stych
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

7.  Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.

Authors:  S R Cummings; D M Black; D E Thompson; W B Applegate; E Barrett-Connor; T A Musliner; L Palermo; R Prineas; S M Rubin; J C Scott; T Vogt; R Wallace; A J Yates; A Z LaCroix
Journal:  JAMA       Date:  1998 Dec 23-30       Impact factor: 56.272

8.  Low-energy femoral shaft fractures associated with alendronate use.

Authors:  Andrew S Neviaser; Joseph M Lane; Brett A Lenart; Folorunsho Edobor-Osula; Dean G Lorich
Journal:  J Orthop Trauma       Date:  2008 May-Jun       Impact factor: 2.512

9.  Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension.

Authors:  Kristine E Ensrud; Elizabeth L Barrett-Connor; Ann Schwartz; Arthur C Santora; Douglas C Bauer; Shailaja Suryawanshi; Adrianne Feldstein; William L Haskell; Marc C Hochberg; James C Torner; Antonio Lombardi; Dennis M Black
Journal:  J Bone Miner Res       Date:  2004-03-29       Impact factor: 6.741

10.  An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?

Authors:  Ernest Beng Kee Kwek; Seo Kiat Goh; Joyce Suang Bee Koh; Meng Ai Png; Tet Sen Howe
Journal:  Injury       Date:  2008-01-28       Impact factor: 2.586

View more
  12 in total

1.  Building bones by knocking down genes.

Authors:  Clifford J Rosen
Journal:  Nat Med       Date:  2012-02-06       Impact factor: 53.440

2.  Editorial: When "safe and effective" becomes dangerous.

Authors:  Seth S Leopold
Journal:  Clin Orthop Relat Res       Date:  2014-05-21       Impact factor: 4.176

3.  Low-energy femoral shaft fractures after long-term alendronate therapy: report of seven cases.

Authors:  Efstathios G Ballas; Andreas F Mavrogenis; Eirineos Karamanis; Zinon T Kokkalis; Evanthia Mitsiokapa; Demetrios Koulalis; Demetrios Mastrokalos; Panayiotis J Papagelopoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-03-28

4.  Progression of bisphosphonate-associated impending atypical femoral fracture despite prophylactic cephalomedullary nailing: A case report and review of literature.

Authors:  Aditya V Maheshwari; Samantha J Yarmis; Justin Tsai; Julio J Jauregui
Journal:  J Clin Orthop Trauma       Date:  2016-06-29

5.  From Bench to Bedside: Detangling Safety and Efficacy for Products and Interventions That May Be Neither.

Authors:  Benjamin K Potter
Journal:  Clin Orthop Relat Res       Date:  2022-06-21       Impact factor: 4.755

Review 6.  Delayed healing of lower limb fractures with bisphosphonate therapy.

Authors:  B Yue; A Ng; H Tang; S Joseph; M Richardson
Journal:  Ann R Coll Surg Engl       Date:  2015-07       Impact factor: 1.891

7.  Propagation of bisphosphonate-related femoral stress fractures despite femoral nailing: a cautionary tale from 2 cases.

Authors:  Christian Fang; Jackie Yee-Man Chau; Siu-Bon Woo; Tak-Wing Lau; Kenny Kwan; Frankie Leung
Journal:  Geriatr Orthop Surg Rehabil       Date:  2014-03

8.  Lateral fixation: an alternative surgical approach in the prevention of complete atypical femoral fractures.

Authors:  Mohammad Kharazmi; Karl Michaëlsson; Pär Hallberg; Jörg Schilcher
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-09-18

9.  Intramedullary Nailing: Definitive as well as Prophylactic Fixation Method in a Case of Bilateral Atypical Femoral Fractures - A Case Report.

Authors:  Vivek Sodhai; Chetan Pradhan; Ashok Shyam
Journal:  J Orthop Case Rep       Date:  2019

10.  Surgical treatment of femoral head fractures.

Authors:  Shih-Hui Peng; Chi-Chuan Wu; Yi-Hsun Yu; Po-Cheng Lee; Ying-Chao Chou; Wen-Lin Yeh
Journal:  Biomed J       Date:  2020-09-30       Impact factor: 4.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.